Similar articles

• Genetic expression of aryl hydrocarbon hydroxylase induction. 3. Changes in the binding of n-octylamine to cytochrome P-450.

  Nebert DW, Gielen JE, Goujon FM. Nebert DW, et al. Mol Pharmacol. 1972 Nov;8(6):651-66. Mol Pharmacol. 1972. PMID: 4118364 No abstract available.
• Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism.

  Robinson JR, Nebert DW. Robinson JR, et al. Mol Pharmacol. 1974 May;10(3):484-93. Mol Pharmacol. 1974. PMID: 4852151 No abstract available.
• Genetic expression of aryl hydrocarbon hydroxylase induction. IV. Interaction of various compounds with different forms of cytochrome P-450 and the effect on benzo(a)pyrene metabolism in vitro.

  Goujon FM, Nebert DW, Gielen JE. Goujon FM, et al. Mol Pharmacol. 1972 Nov;8(6):667-80. Mol Pharmacol. 1972. PMID: 4118365 No abstract available.
• Characterization of rat lung epoxide (styrene oxide) hydrase with a modified radioactive assay of improved sensitivity.

  Seidegård J, DePierre JW, Moron MS, Johannesen KA, Ernster L. Seidegård J, et al. Cancer Res. 1977 Apr;37(4):1075-82. Cancer Res. 1977. PMID: 402999 Review.
• Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds.

  Oesch F. Oesch F. Xenobiotica. 1973 May;3(5):305-40. doi: 10.3109/00498257309151525. Xenobiotica. 1973. PMID: 4584115 Review. No abstract available.